US2014248223A1PendingUtilityA1

Film compositions for delivery of actives

63
Assignee: MONOSOL RX LLCPriority: Oct 12, 2001Filed: Mar 3, 2014Published: Sep 4, 2014
Est. expiryOct 12, 2021(expired)· nominal 20-yr term from priority
A61K 8/731A61K 8/0291A61K 47/38A61K 8/0295B29K 2005/00A61K 8/0204B29K 2001/12A61K 9/7007A61K 8/355A61Q 19/10B82Y 5/00A61Q 5/12A61Q 17/04B29K 2003/00B29C 41/28A61Q 19/00A61K 8/86A61Q 15/00B29K 2001/00A61Q 17/02A61K 8/0216A61Q 17/005A61K 31/74A61Q 5/06A61K 47/10A61Q 5/02A61K 8/0208A61K 2800/413A61Q 9/02
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. Desirably, the films contain at least one active agent, which may be administered to a user topically, transmucosally, vaginally, ocularly, aurally, nasally, transdermally or orally.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A self-supporting film composition comprising:
 (i) a water soluble polymer composition comprising polyethylene oxide and a saccharide-based polymer; and   (ii) a topical agent;   wherein said topical agent is in the form of a small-scale particle selected from the group consisting of at least one type of nanoparticle, at least one type of microparticle, and combinations thereof.   
     
     
         2 . The composition of  claim 1 , wherein said topical agent is in the form of at least one type of liquid crystal. 
     
     
         3 . The composition of  claim 1 , wherein said topical agent is in the form of at least one type of micelle. 
     
     
         4 . The composition of  claim 1 , wherein said topical agent is bound to at least one ligand. 
     
     
         5 . The composition of  claim 1 , wherein said film dosage composition has a substantially uniform distribution of said topical agent. 
     
     
         6 . A dosage composition comprising:
 a. A self-supporting film comprising:
 i. At least one polymer; and 
 ii. At least one agent; 
   wherein said at least one agent is in the form of a small-scale particle selected from the group consisting of at least one type of nanoparticle, at least one type of microparticle, and combinations thereof.   
     
     
         7 . The composition of  claim 6 , wherein said agent is in the form of at least one type of liquid crystal. 
     
     
         8 . The composition of  claim 6 , wherein said agent is in the form of at least one type of micelle. 
     
     
         9 . The composition of  claim 6 , wherein said agent is bound to at least one ligand. 
     
     
         10 . The composition of  claim 6 , wherein said film dosage composition has a substantially uniform distribution of said at least one agent. 
     
     
         11 . A method of forming a self-supporting film dosage composition, comprising the steps of:
 a. Providing a polymeric matrix;   b. Forming a small-scale form of at least one agent;   c. Dispersing said small-scale form of at least one agent throughout said polymeric matrix;   d. Drying said polymeric matrix so as to form a self-supporting film dosage composition comprising said small-scale form of at least one agent;   wherein said small-scale form of at least one agent is selected from the group consisting of at least one type of nanoparticle, at least one type of microparticle, and combinations thereof.   
     
     
         12 . The method of  claim 11 , wherein said agent is in the form of at least one type of microdroplet. 
     
     
         13 . The method of  claim 11 , wherein said agent is in the form of at least one type of micelle. 
     
     
         14 . The method of  claim 11 , wherein said film dosage composition has a substantially uniform distribution of said at least one agent. 
     
     
         15 . The method of  claim 11 , wherein said small-scale form of at least one agent is formed through emulsion processing. 
     
     
         16 . The method of  claim 11 , wherein said small-scale form of at least one agent is formed through milling. 
     
     
         17 . The method of  claim 11 , wherein said small-scale form of at least one agent is formed through processing via a microfluidics pumping apparatus. 
     
     
         18 . The method of  claim 11 , wherein said small-scale form of at least one agent is bound to at least one ligand. 
     
     
         19 . The method of  claim 11 , wherein said step of drying said polymeric matrix comprises heating said polymeric matrix so as to rapidly form a visco-elastic mass to maintain a uniform distribution of said agent by locking-in or substantially preventing migration of said agent within said visco-elastic mass. 
     
     
         20 . The method of  claim 19 , wherein said polymeric matrix containing said agent varies no more than 10% by weight of said agent throughout said polymeric matrix. 
     
     
         21 . The method of  claim 19 , wherein said step of drying said polymeric matrix further comprises further drying said visco-elastic mass so as to provide a self-supporting film dosage composition having a solvent content of 10% or less. 
     
     
         22 . The method of  claim 19 , wherein said step of forming a visco-elastic mass occurs within the first 0.5 to about 10 minutes of heating to maintain a uniform distribution of said agent by locking-in or substantially preventing migration of said agent within said visco-elastic mass. 
     
     
         23 . The method of  claim 22 , wherein said polymeric matrix containing said agent varies no more than 10% by weight of said agent throughout said polymeric matrix. 
     
     
         24 . The method of  claim 22 , wherein said step of drying said polymeric matrix further comprises further drying said visco-elastic mass so as to provide a self-supporting film dosage composition having a solvent content of 10% or less. 
     
     
         25 . The method of  claim 11 , wherein said small-scale form of at least one agent is formed through processing via a high shear apparatus. 
     
     
         26 . The method of  claim 11 , wherein said small-scale form of said agent is in the form of at least one liquid crystal. 
     
     
         27 . A method of forming a self-supporting film dosage composition, comprising the steps of:
 a. Providing a polymeric matrix;   b. Forming a small-scale form of at least one agent;   c. Applying said small-scale form of at least one agent to said polymeric matrix via deposition; and   d. Drying said polymeric matrix so as to form a self-supporting film dosage composition comprising said small-scale form of at least one agent.   
     
     
         28 . The method of  claim 27 , wherein said agent is in the form of at least one type of microdroplet. 
     
     
         29 . The method of  claim 27 , wherein said agent is in the form of at least one type of micelle. 
     
     
         30 . The method of  claim 27 , wherein said small-scale form of at least one agent is formed through emulsion processing. 
     
     
         31 . The method of  claim 27 , wherein said small-scale form of at least one agent is formed through milling. 
     
     
         32 . The method of  claim 27 , wherein said small-scale form of at least one agent is formed through processing via a microfluidics pumping apparatus. 
     
     
         33 . The method of  claim 27 , wherein said small-scale form of at least one agent is bound to at least one ligand. 
     
     
         34 . The method of  claim 27 , wherein said small-scale form of at least one agent is formed through processing via a high shear apparatus. 
     
     
         35 . The method of  claim 27 , wherein said small-scale form of said agent is in the form of at least one liquid crystal.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.